Krishna Institute of Medical Sciences Ltd
Krishna Medical Institution Ltd (KIMS) was Incorporated in the year 1973 and is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered. The company offers multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities and an additional quaternary healthcare facility in tier-1 cities.
- Market Cap ₹ 30,284 Cr.
- Current Price ₹ 757
- High / Low ₹ 798 / 576
- Stock P/E 122
- Book Value ₹ 56.2
- Dividend Yield 0.00 %
- ROCE 9.29 %
- ROE 11.3 %
- Face Value ₹ 2.00
Pros
- Company is expected to give good quarter
- Company's median sales growth is 21.9% of last 10 years
Cons
- Stock is trading at 13.5 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company might be capitalizing the interest cost
- Promoter holding has decreased over last 3 years: -4.73%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap Select Index BSE 250 SmallCap Index
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 512 | 567 | 664 | 918 | 1,123 | 1,330 | 1,651 | 2,198 | 2,498 | 3,035 | 3,905 | |
| 403 | 450 | 593 | 833 | 872 | 953 | 1,126 | 1,587 | 1,850 | 2,242 | 3,103 | |
| Operating Profit | 109 | 118 | 71 | 85 | 251 | 377 | 524 | 611 | 648 | 793 | 802 |
| OPM % | 21% | 21% | 11% | 9% | 22% | 28% | 32% | 28% | 26% | 26% | 21% |
| 5 | 3 | 37 | 6 | 5 | 9 | 27 | 41 | 13 | 43 | 18 | |
| Interest | 37 | 32 | 88 | 49 | 44 | 37 | 22 | 37 | 55 | 100 | 202 |
| Depreciation | 36 | 35 | 40 | 56 | 71 | 70 | 73 | 129 | 147 | 177 | 283 |
| Profit before tax | 41 | 53 | -20 | -15 | 141 | 279 | 457 | 485 | 460 | 558 | 334 |
| Tax % | 32% | 37% | 126% | 223% | 18% | 26% | 25% | 25% | 27% | 26% | 28% |
| 28 | 33 | -46 | -49 | 115 | 205 | 344 | 366 | 336 | 415 | 242 | |
| EPS in Rs | 0.76 | 0.91 | -1.32 | -1.28 | 3.20 | 5.19 | 8.32 | 8.41 | 7.75 | 9.61 | 6.03 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 24% |
| 3 Years: | 21% |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 4% |
| 3 Years: | -9% |
| TTM: | -32% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 33% |
| 1 Year: | 12% |
| Return on Equity | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 18% |
| 3 Years: | 16% |
| Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 70 | 72 | 50 | 74 | 74 | 78 | 80 | 80 | 80 | 80 | 80 |
| Reserves | 193 | 255 | -209 | 466 | 524 | 786 | 1,307 | 1,590 | 1,748 | 2,058 | 2,167 |
| 256 | 280 | 753 | 336 | 369 | 316 | 257 | 678 | 1,355 | 2,557 | 4,253 | |
| 146 | 167 | 359 | 237 | 228 | 253 | 260 | 553 | 636 | 995 | 1,258 | |
| Total Liabilities | 665 | 774 | 954 | 1,114 | 1,194 | 1,433 | 1,904 | 2,901 | 3,820 | 5,689 | 7,759 |
| 515 | 518 | 755 | 863 | 916 | 931 | 1,005 | 1,766 | 2,434 | 3,348 | 5,710 | |
| CWIP | 2 | 64 | 0 | 0 | 2 | 9 | 21 | 477 | 600 | 1,214 | 606 |
| Investments | 11 | 14 | 0 | 0 | 0 | 0 | 332 | 68 | 157 | 99 | 103 |
| 137 | 177 | 199 | 250 | 276 | 493 | 546 | 590 | 629 | 1,028 | 1,339 | |
| Total Assets | 665 | 774 | 954 | 1,114 | 1,194 | 1,433 | 1,904 | 2,901 | 3,820 | 5,689 | 7,759 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 95 | 82 | 106 | 134 | 202 | 356 | 324 | 432 | 521 | 582 | 511 | |
| -41 | -100 | -64 | -110 | -125 | -354 | -412 | -416 | -753 | -1,116 | -1,452 | |
| -65 | 24 | -39 | -27 | -44 | 10 | 61 | 20 | 217 | 543 | 940 | |
| Net Cash Flow | -11 | 5 | 3 | -3 | 32 | 12 | -26 | 36 | -15 | 9 | -1 |
| Free Cash Flow | 61 | -18 | 49 | 57 | 150 | 262 | 154 | -140 | -125 | -380 | -902 |
| CFO/OP | 88% | 80% | 192% | 195% | 102% | 104% | 86% | 87% | 102% | 91% | 83% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 47 | 59 | 59 | 49 | 43 | 30 | 28 | 42 | 43 | 48 | 52 |
| Inventory Days | 36 | 43 | 46 | 47 | 44 | 30 | 37 | 44 | |||
| Days Payable | 194 | 207 | 215 | 181 | 177 | 167 | 133 | 146 | |||
| Cash Conversion Cycle | -111 | -105 | -110 | -85 | -91 | -106 | -67 | 42 | 43 | 48 | -50 |
| Working Capital Days | 11 | 26 | -333 | -15 | -15 | -31 | -3 | 8 | -5 | -29 | -35 |
| ROCE % | 15% | 11% | 5% | 20% | 29% | 34% | 24% | 17% | 15% | 9% |
Insights
In beta| Mar 2005 | Mar 2010 | Mar 2015 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Hospitals Number |
|
||||||||||
| ALOS (Average Length of Stay) Days |
|||||||||||
| ARPOB (Average Revenue Per Occupied Bed) INR |
|||||||||||
| Bed Capacity Number |
|||||||||||
| Inpatient (IP) Volume Number |
|||||||||||
| Occupancy Percentage % |
|||||||||||
| Operational Beds Number |
|||||||||||
| Outpatient (OP) Volume Number |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
22 May - Transcript of conference call with investors held on 18.05.2026
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
20 May - Intimation of Schedule of analyst or institutional investor meetings
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
18 May - Audio recording of Q4 FY26 investor conference call posted on company website.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
16 May - KIMS reported FY26 revenue of INR 3,931 Cr and PAT of INR 242 Cr on 16 May 2026.
- Announcement under Regulation 30 (LODR)-Investor Presentation 16 May
Annual reports
Concalls
-
May 2026Transcript PPT REC
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Nov 2025TranscriptAI SummaryPPT
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023TranscriptPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022TranscriptAI SummaryPPT
-
May 2022Transcript PPT
-
May 2022TranscriptAI SummaryPPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Oct 2021TranscriptAI SummaryPPT
-
Aug 2021Transcript PPT
Regional Leadership
KIMS Hospitals is one of the largest corporate healthcare groups in Telangana and AP, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost. The Group offers healthcare services in specialties and super specialties across more than 40 fields. [1]